Novo Nordisk A/S
Does not own any stock in company, Has had impressive sales record with organic growth. Pressure on diabetes pricing in the USA. Expecting new products coming onto market to benefit the company. Large portion if US(40%) living with obesity. Expensive at current share price.
Pharma & Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Novo Nordisk A/S(NOVO-B) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Novo Nordisk A/S is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Novo Nordisk A/S(NOVO-B) Frequently Asked Questions

What is Novo Nordisk A/S stock symbol?

Novo Nordisk A/S is a OTC stock, trading under the symbol NOVO-B on the (). It is usually referred to as or NOVO-B

Is Novo Nordisk A/S a buy or a sell?

In the last year, 1 stock analyst published opinions about NOVO-B. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Novo Nordisk A/S.

Is Novo Nordisk A/S a good investment or a top pick?

Novo Nordisk A/S was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Novo Nordisk A/S.

Why is Novo Nordisk A/S stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Novo Nordisk A/S worth watching?

In the last year, there was no coverage of Novo Nordisk A/S published on Stockchase.

What is Novo Nordisk A/S stock price?

On , Novo Nordisk A/S (NOVO-B) stock closed at a price of $.